| QUVIVIQ Idorsia Pharmaceuticals Ltd
79350361 06 Jul 2022 | on 02 Apr 2024
| Pharmaceutical preparations intended for the prevention or treatment o... Class 005 Class 005 Pharmaceutical Products The mark consists of the stylized wording "QUVIVIQ" with five circles formingan arch over the "VIV" letters in the mark. | | | I Idorsia Pharmaceuticals Ltd
88716747 05 Dec 2019 | on 06 Dec 2022
| Pharmaceutical preparations for the prevention or treatment of neurolo... Class 005 Class 005 Pharmaceutical Products The mark consists of a stylized lower case "i" including an upper arm atop the stem. The dot of the "i" appears above the left part of the upper arm. | | | IDSIQ Idorsia Pharmaceuticals Ltd
79308218 30 Dec 2020 | on 24 May 2022
| Multimedia publication of printed matter in the nature of newsletters,... Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Multimedia publication of printed matter in the nature of newsletters, brochures, and test results in the nature of test results documents and test result forms in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; multimedia publication of printed matter in the nature of books, magazines and journals in the field of tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients Class 016 Class 016 Paper Goods and Printed Material Downloadable electronic publications in the nature of newsletters and test results in the nature of test results documents and test result forms the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients Class 041 Education and Entertainment Services Printed matter in the nature of newsletters and brochures in the field of medical tests which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients and in the field of collection of medical data which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients
Class 042 Computer & Software Services & Scientific Services Scientific research and development, namely pharmaceutical testing and medical testing services not for diagnostic or treatment purposes and development of pharmaceutical and medical tests, all which are used for identifying symptoms of insomnia in patients and the effects of insomnia disorders on patients or symptoms of mental disorders associated with insomnia in patients and the effects of mental disorders associated with insomnia disorders on patients; scientific research, namely analysis of objective data on patients that was acquired by means of diagnostic tests in the context of drug administration, analysis of subjective data on patients that was acquired by means of patient questioning, analysis of such data with the aim of optimizing drug treatments and drug administration | | | PIVLAZ Idorsia Pharmaceuticals Ltd
79299721 07 Oct 2020 | on 11 Jan 2022
| Pharmaceutical preparations for treatment of cerebral hemorrhages and ... Class 005 Class 005 Pharmaceutical Products The mark consists of three wavy lines forming the general shape of a rhombus to the left of the wording "PIVLAZ". | | | QUVIVIQ Idorsia Pharmaceuticals Ltd
79299719 08 Oct 2020 | on 24 Aug 2021
| Pharmaceutical preparations for humans for the prevention and treatmen... Class 005 Class 005 Pharmaceutical Products The mark consists of the stylized wording "QUVIVIQ" with a shaded triangle appearing under the letters "VIV". | | | RYAMRA Idorsia Pharmaceuticals Ltd
79274312 06 Nov 2019 | on 03 Nov 2020
| Pharmaceutical preparations for humans for the prevention and treatmen... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, vasospasm associated with aneurysmal subarachnoid hemorrhage, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases, neurological disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer | | | KENLIFA Idorsia Pharmaceuticals Ltd
79275362 05 Nov 2019 | on 03 Nov 2020
| Pharmaceutical preparations for the prevention or treatment of cardiov... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention or treatment of cardiovascular diseases, hypertension, brain haemorrhage and sequelae thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer | | | QUVIVIQ Idorsia Pharmaceuticals Ltd
79274313 05 Nov 2019 | on 06 Oct 2020
| Pharmaceutical preparations for humans for the prevention and treatmen... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, brain haemorrhage and sequelae thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer | | | JOFABYO Idorsia Pharmaceuticals Ltd
79255008 01 Feb 2019 | on 03 Mar 2020
| Pharmaceutical preparations for the treatment of cardiovascular and pu... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, neurodegenerative diseases, neurological disorders, anxiety, addictions including addictive eating disorders, and neurodegenerative disorders including Alzheimer's disease, diseases of the central nervous system, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, and allergic diseases | | | PIVLAZ Idorsia Pharmaceuticals Ltd.
79245536 12 Oct 2018 | on 26 Nov 2019
| Pharmaceutical preparations for cardiovascular, pulmonary, inflammator... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for cardiovascular, pulmonary, inflammatory indications, for the treatment of pathological incidents of the central nervous system, in particular subarachnoid hemorrhage and sequelae thereof, as well as for the treatment of cancer | | 
